
Sun Pharma Advanced Research Company Hits Intraday High with Strong Trading Momentum
2025-12-03 09:32:14Sun Pharma Advanced Research Company recorded a robust intraday performance today, reaching a high of Rs 174.25, reflecting an 8.16% rise during the trading session. The stock outpaced its sector and broader market indices, demonstrating notable volatility and sustained upward momentum.
Read MoreWhy is SPARC falling/rising?
2025-12-03 00:39:31Intraday Price Movement and Market Context SPARC's price surged by ₹26.85, reaching an intraday high of ₹161.10, reflecting a strong rebound after recent losses. The stock outperformed its sector by nearly 20% on the day, while the broader Sensex index recorded a modest gain of 0.65% over the past week. This outperformance is particularly striking given the stock’s longer-term underperformance relative to the benchmark. Over the past week and month, SPARC has delivered returns of +21.08% and +19.29% respectively, dwarfing the Sensex’s 0.65% and 1.43% gains for the same periods. Despite this short-term rally, the stock remains down 19.55% year-to-date and has underperformed the Sensex by a wide margin over the last one, three, and five years. The 1-year return stands at...
Read More
Sun Pharma Advanced Research Company Surges with Unprecedented Buying Interest
2025-12-02 13:20:49Sun Pharma Advanced Research Company Ltd has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and only buy orders in the queue, signalling a potential multi-day rally amid strong investor enthusiasm.
Read More
Sun Pharma Advanced Research Company Hits Intraday High with Strong Trading Momentum
2025-12-02 09:32:05Sun Pharma Advanced Research Company recorded a robust intraday performance today, reaching a high of Rs 145.95, reflecting an 8.72% rise amid heightened volatility and notable trading activity.
Read More
SPARC’s Evaluation Revised Amidst Challenging Financial and Market Conditions
2025-11-28 10:05:12SPARC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. This shift highlights the company’s current standing amid a difficult market environment and persistent underperformance relative to its peers and benchmarks.
Read More
Sun Pharma Advanced Research Company Shows Mixed Technical Signals Amid Price Momentum Shift
2025-11-28 08:04:36Sun Pharma Advanced Research Company (SPARC) has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. Recent data reveals a transition from a predominantly bearish stance to a mildly bearish outlook, with key technical indicators such as MACD, RSI, and moving averages presenting a complex picture for investors analysing the pharmaceutical and biotechnology sector.
Read More
Sun Pharma Advanced Research Company Faces Technical Momentum Shift Amid Market Challenges
2025-11-25 08:09:18Sun Pharma Advanced Research Company (SPARC) is currently exhibiting a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent evaluation adjustments highlight a transition in key technical indicators, signalling a more cautious outlook for investors amid broader market pressures.
Read More
Sun Pharma Advanced Research Company Sees Shift in Technical Momentum Amid Market Volatility
2025-11-21 08:06:18Sun Pharma Advanced Research Company (SPARC) has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and investor sentiment within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a nuanced transition in the stock’s trend, warranting close attention from market participants.
Read MoreWhy is SPARC falling/rising?
2025-11-18 22:12:11As of 18-Nov, Sun Pharma Advanced Research Company Ltd is experiencing a decline in its stock price, currently at 129.35, which represents a decrease of 2.25 or 1.71%. The stock has underperformed its sector by 1.09% today and has been on a consecutive downward trend for the last two days, with a total return drop of 1.97%. Additionally, the stock is trading below its moving averages across all time frames, indicating a bearish trend. The company has reported negative financial results, including a significant drop in net sales and operating profit, contributing to a negative book value and weak long-term fundamentals. The stock's performance has been consistently poor, with a year-to-date decline of 35.41% compared to a positive return of 8.36% for the benchmark. In the broader market context, the stock's short-term performance has been notably weaker than the benchmark, with a 1-week return of -1.33% com...
Read MoreClarification sought from Sun Pharma Advanced Research Company Ltd
02-Feb-2026 | Source : BSEThe Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on February 2 2026 with reference to Movement in Volume.
The reply is awaited.
Clarification Regarding Increase In Volume
02-Feb-2026 | Source : BSEResponse of Clarification sought from BSE Limited
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-Jan-2026 | Source : BSENewspaper Advertisement for Corrigendum to the Notice of Extra Ordinary General Meeting of the Company
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Sun Pharma Advanced Research Company Ltd has announced 5:116 rights issue, ex-date: 16 Mar 16